FLGT — Fulgent Genetics Share News
0.000.00%
- $587.18m
- $328.54m
- $322.67m
U.S. STOCKS ON THE MOVE-Clarus Corp, Alaska Air, Dollar Tree
U.S. STOCKS ON THE MOVE-Alphabet, Caterpillar, Chevron Corp
Fulgent Genetics bounces on $250 mln stock buyback plan
Brief: Fulgent Genetics Announces $250 Mln Share Repurchase Program
Brief: Epic Sciences, Fulgent Genetics Collaborate To Deliver Definembc Results For Metastatic Breast Cancer Patients
Fulgent Genetics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Fulgent Genetics Reports Q4 And Full Year 2021 Results
Fulgent Genetics Inc expected to post earnings of $2.61 a share - Earnings Preview
Brief: Fulgent Genetics Confirms Ability To Detect Omicron Variant With Rt-Pcr Tests For Covid-19
Fulgent Genetics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Fulgent Genetics Posts Q3 EPS Of $3.93
Brief: Helio Health, Fulgent Genetics to Present New Data on HelioLiver at The Liver Meeting 2021
Brief: Fulgent Genetics Inc Launches At-Home Neutralizing Antibody Test For Covid-19
Brief: Fulgent Genetics To Partner With Houston Health Department
U.S. RESEARCH ROUNDUP-Bluebird Bio, Smiledirectclub, Whitehorse Finance
Fulgent Genetics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Fulgent Genetics Posts Q2 EPS Of $2.59
Brief: Fulgent Genetics And Helio Health Announce Strategic Partnership To Commercialize Early Cancer Detection Tests
Fulgent Genetics Inc expected to post earnings of $2.76 a share - Earnings Preview